Genome-edited baby claim provokes international outcry

@article{Cyranoski2018GenomeeditedBC,
  title={Genome-edited baby claim provokes international outcry},
  author={David Cyranoski and Heidi Ledford},
  journal={Nature},
  year={2018},
  volume={563},
  pages={607-608}
}
The startling announcement by a Chinese scientist represents a controversial leap in the use of genome editing.The startling announcement by a Chinese scientist represents a controversial leap in the use of genome-editing. 
An Exclusive Interview With CRISPR.
This article chronicles a didactic encounter between an ethics-minded physician-scientist and a personified genome editing technology called clustered regularly interspaced short palindromic repeats
Editing the Gene Editing Debate: Reassessing the Normative Discussions on Emerging Genetic Technologies
The revolutionary potential of the CRISPR-Cas9 gene editing technique has created a resurgence in enthusiasm and concern in genetic research perhaps not seen since the mapping of the human genome at
CRISPR’d babies: human germline genome editing in the ‘He Jiankui affair’*
  • H. Greely
  • Art
    Journal of law and the biosciences
  • 2019
TLDR
This article is an effort to provide some deep context for the He Jiankui affair and to begin analyzing it, including a detailed narrative of the revelation of the He experiment and its fallout.
Governance of gene editing in South Africa: Towards addressing the ethico-legal hiatus
TLDR
The First South African Conference on Gene Editing brought together local and international experts at the end of November 2019 to discuss and debate issues and to inform appropriate and relevant recommendations.
Legal framework for gene editing in human genome “ World ’ s First Mutant twins by China ”
TLDR
Whether the legislation that specifically address the issue of Assistive Reproductive Technology research and Human Embryo Stem Cell research are sufficient and provide sustainable legal framework that is pertinent to the regulatory control of this research in China is addressed.
Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.
TLDR
It is found SCD stakeholders hold a nuanced view of HGE, and assuming the technology is shown to be safe and effective, they are just as supportive of H GE as genetics professionals, but more supportive than the general public.
...
...